Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Proguanil

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 992Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Netherlands plans ‘world’s first’ test of anti-malarial drugs against corona
    Netherlands plans ‘world’s first’ test of anti-malarial drugs against corona

    10 Apr 2020

    // DUTCHNEWS

    https://www.dutchnews.nl/news/2020/04/netherlands-plans-worlds-first-scientific-test-of-anti-malarial-drugs-against-corona/

    DUTCHNEWS
    10 Apr 2020
    Share Share
    Glenmark opens $100M plant in North Carolina, its first in U.S.
    Glenmark opens $100M plant in North Carolina, its first in U.S.

    30 Oct 2018

    // Eric Palmer FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/glenmark-opens-100m-plant-north-carolina

    Eric Palmer FIERCE PHARMA
    30 Oct 2018
    Share Share
    Glenmark Pharma receives final approval by MHRA for Maloff Protect
    Glenmark Pharma receives final approval by MHRA for Maloff Protect

    04 Jul 2017

    // INDIAINFOLINE

    http://www.indiainfoline.com/article/news-top-story/glenmark-pharma-receives-approval-glenmark-pharma-receives-final-approval-by-mhra-for-maloff-protect-117070400297_1.html

    INDIAINFOLINE
    04 Jul 2017
    Share Share